Product Information

PHENOBARBITAL 60 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1699 per EA under NDC 00143145505. Its NADAC has been published 596 times since Nov 28, 2013.

PHENOBARBITAL 60 MG TABLET

Phenobarbital
$0.1699per EA
DEA Schedule CIV

Strength

60 mg/1

NDC

00143145505

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

PHENOBARBITAL

Approval Type

Unapproved

On Market Since

1/11/1999

Price Statistics

The NADAC for PHENOBARBITAL 60 MG TABLET has been published 596 times since Nov 28, 2013, and over the history we have for it it has declined 20.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1699 per EA
All-time high$0.3618 (Nov 13, 2019)
All-time low$0.1283 (Nov 20, 2024)
52-week high$0.2202
52-week low$0.1699
Median price$0.2287
Average price$0.2433
Largest weekly change-49.9% (Nov 20, 2024)
Weeks tracked596
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-4.8%

3M

-12.5%

6M

-19.7%

1Y

-22.3%

3Y

-35.0%

5Y

-50.7%

All

-20.4%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PHENOBARBITAL 60 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 60 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1699 per EA (NDC 00143145505), effective Jun 24, 2026.

How has the price of PHENOBARBITAL 60 MG TABLET changed over time?

Over the history we have for it, the NADAC for PHENOBARBITAL 60 MG TABLET has declined 20.4%. It has been tracked across 596 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 60 MG TABLET?

Since Nov 28, 2013, the NADAC for PHENOBARBITAL 60 MG TABLET has ranged from a low of $0.1283 (Nov 20, 2024) to a high of $0.3618 (Nov 13, 2019), with a median of $0.2287 per EA.

Are there cheaper alternatives to PHENOBARBITAL 60 MG TABLET?

5 NADAC-published products share the same active ingredient, strength, and dosage form as PHENOBARBITAL 60 MG TABLET, but none are currently priced below it.

Who manufactures PHENOBARBITAL 60 MG TABLET?

PHENOBARBITAL 60 MG TABLET (NDC 00143145505) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.